ArticleMedicine2017

Recombinant human thrombopoietin improves the efficacy of intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor in mobilizing peripheral blood stem cells in patients with multiple myeloma: A cohort study.

Guorong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.